BioMarin Pharmaceutical Inc. (BMRN) Discounted Future Market Cap - Discounting Cash Flows
BioMarin Pharmaceutical Inc.
BMRN (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value -0.804 USD
Estimated net income -9.81 Mil. USD
Estimated market capitalization -196.1 Mil. USD
Market capitalization discounted to present -153.5 Mil. USD
Shares Outstanding 191 Mil.
Earnings Per Share (EPS) 2.75 USD
Market Price 54.97 USD
Price to Earnings (PE) Ratio 20.04

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue 2,854 2,938 2,823 3,202 3,632 4,119 4,672
Revenue Growth Rate 17.97% 2.94% -1.07% 13.42% 13.42% 13.42% 13.42%
Net Income 426.9 523.9 -5.93 -6.72 -7.63 -8.65 -9.81

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 1,866 2,938 2,854 2,419 2,096 1,846 1,860 1,704 1,491 1,314 1,117 889.9
Cost of Revenue 412.3 620.9 580.2 577.1 483.7 470.5 524.3 359.5 315.3 241.8 209.6 152
Gross Profit 1,454 2,317 2,274 1,842 1,612 1,376 1,336 1,345 1,176 1,072 907.2 737.9
Gross Margin 78.31% 78.86% 79.67% 76.15% 76.92% 74.52% 71.82% 78.91% 78.86% 81.59% 81.23% 82.92%
Operating Income 0.433 602.7 484.2 194.4 57.55 -60.01 -96.26 -125.5 -123.5 -14.7 -803.4 -110.7
Operating Margin -5.57% 20.51% 16.97% 8.04% 2.74% -3.25% -5.17% -7.36% -8.28% -1.12% -71.94% -12.44%
Net Income 93.62 523.9 426.9 167.6 141.6 -64.08 854 -23.85 -77.21 -117 -630.2 -171.8
Net Margin -0.211% 17.83% 14.96% 6.93% 6.75% -3.47% 45.9% -1.4% -5.18% -8.91% -56.43% -19.31%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 1,866 2,938 2,854 2,419 2,096 1,846 1,860 1,704 1,491 1,314 1,117 889.9
Revenue Growth Rate 13.42% 2.94% 17.97% 15.42% 13.53% -0.762% 9.18% 14.27% 13.52% 17.62% 25.5% 18.49%
Net Income 93.62 523.9 426.9 167.6 141.6 -64.08 854 -23.85 -77.21 -117 -630.2 -171.8
Net Margin -0.211% 17.83% 14.96% 6.93% 6.75% -3.47% 45.9% -1.4% -5.18% -8.91% -56.43% -19.31%
Net Income Growth Rate -345.7% 22.73% 154.6% 18.43% -320.9% -107.5% -3,681% -69.11% -34.03% -81.43% 266.8% 28.24%
Stockholders Equity 3,950 5,793 5,658 4,952 4,603 4,271 4,106 3,122 2,968 2,809 2,766 2,401
Equity Growth Rate 13.84% 2.39% 14.27% 7.57% 7.78% 4.01% 31.5% 5.2% 5.67% 1.53% 15.22% 57.13%
Return on Invested Capital (ROIC) 2.98% 8.56% 7.01% 3.52% 1.08% -1.05% 41.52% -0.95% -1.96% -1.49% -19.18% -4.26%
After-tax Operating Income 191 468.2 381.5 172.9 54.46 -51.04 1,954 -31.56 -66.83 -47.96 -609.3 -122.9
Income Tax Rate 192.1% 22.31% 21.21% 11.09% 5.36% 14.96% 2,130% 74.85% 45.89% -226.2% 24.17% -11.04%
Invested Capital 4,225 5,470 5,439 4,909 5,062 4,876 4,706 3,320 3,410 3,219 3,176 2,887
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us